Investor Relations Investor Center Stock Information Financial Information Corporate Governance Press Releases Events & Presentations Investor FAQ Contact Us
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Provides Update On NASDAQ Listing Nov 03, 2010 Tekmira Provides Update On NASDAQ Listing 17.9 KB ... Read more Summary ToggleTekmira and Collaborators at the NCI Publish Promising Preclinical Data Demonstrating Anti-Tumor Activity of a Novel Cancer Target via RNA Interference Oct 21, 2010 Tekmira and Collaborators at the NCI Publish Promising Preclinical Data Demonstrating Anti-Tumor Activity of a Novel Cancer Target via RNA Interference 19.1 KB ... Read more Summary ToggleTekmira and Collaborators Awarded $2.4 Million NIH Grant for Development of RNAi Therapeutics to Treat Ebola and Marburg Viral Infections Oct 13, 2010 Tekmira and Collaborators Awarded $2.4 Million NIH Grant for Development of RNAi Therapeutics to Treat Ebola and Marburg Viral Infections 20 KB ... Read more Summary ToggleTekmira Intellectual Property Portfolio Solidified with Granting of Key Patents by US Patent & Trademark Office Oct 06, 2010 Tekmira Intellectual Property Portfolio Solidified with Granting of Key Patents by US Patent & Trademark Office 19.1 KB -Claims Cover Lipid Nanoparticles and Key Lipid Components of Tekmira’s Leading Technology- ... Read more Summary ToggleTekmira Pharmaceuticals Amends Agreement with Legacy Partner Hana Biosciences Sep 21, 2010 Tekmira Pharmaceuticals Amends Agreement with Legacy Partner Hana Biosciences 18.3 KB ... Read more Summary ToggleTekmira Pharmaceuticals Provides Corporate Update Sep 10, 2010 ... Read more Summary ToggleTekmira Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference and the Stifel Nicolaus Healthcare Conference Sep 09, 2010 Tekmira Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference and the Stifel Nicolaus Healthcare Conference 13.7 KB ... Read more Summary ToggleTekmira Pharmaceuticals Strengthens Management Team with Addition of Paul Brennan as Senior Vice President, Business Development Sep 08, 2010 Tekmira Pharmaceuticals Strengthens Management Team with Addition of Paul Brennan as Senior Vice President, Business Development 17.8 KB ... Read more Summary ToggleTekmira Pharmaceuticals Receives Clearance from FDA to Initiate TKM-PLK1 Phase 1 Clinical Trial Sep 07, 2010 Tekmira Pharmaceuticals Receives Clearance from FDA to Initiate TKM-PLK1 Phase 1 Clinical Trial 18.5 KB ... Read more Summary ToggleTekmira Pharmaceuticals Announces Second Quarter 2010 Financial Results Aug 12, 2010 Tekmira Pharmaceuticals Announces Second Quarter 2010 Financial Results 30.4 KB ... Read more Pagination First page First Previous page Previous … Page 44 Current page 45 Page 46 Page 47 … Next page Next Last page Last Shareholder Tools Email Alerts Email Alerts RSS News Feeds RSS News Feeds Download Library Download Library
Press Releases Year: - Any -202420232022202120202019201820172016201520142013201220112010200920082007 Summary ToggleTekmira Provides Update On NASDAQ Listing Nov 03, 2010 Tekmira Provides Update On NASDAQ Listing 17.9 KB ... Read more Summary ToggleTekmira and Collaborators at the NCI Publish Promising Preclinical Data Demonstrating Anti-Tumor Activity of a Novel Cancer Target via RNA Interference Oct 21, 2010 Tekmira and Collaborators at the NCI Publish Promising Preclinical Data Demonstrating Anti-Tumor Activity of a Novel Cancer Target via RNA Interference 19.1 KB ... Read more Summary ToggleTekmira and Collaborators Awarded $2.4 Million NIH Grant for Development of RNAi Therapeutics to Treat Ebola and Marburg Viral Infections Oct 13, 2010 Tekmira and Collaborators Awarded $2.4 Million NIH Grant for Development of RNAi Therapeutics to Treat Ebola and Marburg Viral Infections 20 KB ... Read more Summary ToggleTekmira Intellectual Property Portfolio Solidified with Granting of Key Patents by US Patent & Trademark Office Oct 06, 2010 Tekmira Intellectual Property Portfolio Solidified with Granting of Key Patents by US Patent & Trademark Office 19.1 KB -Claims Cover Lipid Nanoparticles and Key Lipid Components of Tekmira’s Leading Technology- ... Read more Summary ToggleTekmira Pharmaceuticals Amends Agreement with Legacy Partner Hana Biosciences Sep 21, 2010 Tekmira Pharmaceuticals Amends Agreement with Legacy Partner Hana Biosciences 18.3 KB ... Read more Summary ToggleTekmira Pharmaceuticals Provides Corporate Update Sep 10, 2010 ... Read more Summary ToggleTekmira Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference and the Stifel Nicolaus Healthcare Conference Sep 09, 2010 Tekmira Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference and the Stifel Nicolaus Healthcare Conference 13.7 KB ... Read more Summary ToggleTekmira Pharmaceuticals Strengthens Management Team with Addition of Paul Brennan as Senior Vice President, Business Development Sep 08, 2010 Tekmira Pharmaceuticals Strengthens Management Team with Addition of Paul Brennan as Senior Vice President, Business Development 17.8 KB ... Read more Summary ToggleTekmira Pharmaceuticals Receives Clearance from FDA to Initiate TKM-PLK1 Phase 1 Clinical Trial Sep 07, 2010 Tekmira Pharmaceuticals Receives Clearance from FDA to Initiate TKM-PLK1 Phase 1 Clinical Trial 18.5 KB ... Read more Summary ToggleTekmira Pharmaceuticals Announces Second Quarter 2010 Financial Results Aug 12, 2010 Tekmira Pharmaceuticals Announces Second Quarter 2010 Financial Results 30.4 KB ... Read more Pagination First page First Previous page Previous … Page 44 Current page 45 Page 46 Page 47 … Next page Next Last page Last
Tekmira and Collaborators at the NCI Publish Promising Preclinical Data Demonstrating Anti-Tumor Activity of a Novel Cancer Target via RNA Interference 19.1 KB
Tekmira and Collaborators Awarded $2.4 Million NIH Grant for Development of RNAi Therapeutics to Treat Ebola and Marburg Viral Infections 20 KB
Tekmira Intellectual Property Portfolio Solidified with Granting of Key Patents by US Patent & Trademark Office 19.1 KB
Tekmira Pharmaceuticals to Present at the Rodman & Renshaw Annual Global Investment Conference and the Stifel Nicolaus Healthcare Conference 13.7 KB
Tekmira Pharmaceuticals Strengthens Management Team with Addition of Paul Brennan as Senior Vice President, Business Development 17.8 KB
Tekmira Pharmaceuticals Receives Clearance from FDA to Initiate TKM-PLK1 Phase 1 Clinical Trial 18.5 KB
